SINGAPORE (May 18): Hyphens Pharma International, the latest healthcare stock making it Catalist debut this morning, opened at 30 cents, 15.4% higher than its IPO price of 26 cents.

As at 11.59am, the stock was trading at 28.5 cents with some 17.4 million shares changing hands.

Hyphens Pharma has three income streams. One is the specialty pharmaceutical segment involved in the selling and marketing of specialty pharmaceutical products from brands such as Guerbet and Bausch+Lomb.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook